---
title: "SL PHARM: GLP-1 long-acting products are organizing materials in preparation for reporting"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/263923652.md"
description: "On November 3rd, SL PHARM stated on the interactive platform that the company's GLP-1 long-acting product is currently organizing materials in preparation for submission"
datetime: "2025-11-03T01:17:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263923652.md)
  - [en](https://longbridge.com/en/news/263923652.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263923652.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/263923652.md) | [繁體中文](https://longbridge.com/zh-HK/news/263923652.md)


# SL PHARM: GLP-1 long-acting products are organizing materials in preparation for reporting

On November 3rd, SL PHARM stated on the interactive platform that the company's GLP-1 long-acting product is currently organizing materials in preparation for submission

### 相关股票

- [SL PHARM (002038.CN)](https://longbridge.com/zh-CN/quote/002038.CN.md)

## 相关资讯与研究

- [08:38 ETLunakai Naturally Stimulates Endogenous GLP-1 Secretion](https://longbridge.com/zh-CN/news/278392686.md)
- [PegBio's GLP-1 Candidate Completes First-in-Human Dosing](https://longbridge.com/zh-CN/news/278319911.md)
- [Lindt says GLP-1 users are eating more chocolate, not less](https://longbridge.com/zh-CN/news/278518018.md)
- [09:00 ETPureHealth Research Launches Doctor-Approved Natural GLP-1 Supplements Collection for Metabolic Support](https://longbridge.com/zh-CN/news/278219735.md)
- [Pfizer Gains Chinese Approval for GLP-1 Weight Management Drug Enochlutide](https://longbridge.com/zh-CN/news/278064724.md)